iC42 Lab
Clinical Research, Clinical Diagnostics, Therapeutic Drug Monitoring, Toxicology, Pharmacokinetics
iC42 Clinical Research and Development is a global bioanalytical Service Center that combines quantitative mass spectrometry, metabolic and protein profiling technologies in a regulatory compliant environment under one roof.
Their strength and emphasis lie in the assessment of vascular endothelial dysfunction markers and pediatric pharmacological solutions. Research and development of innovative individualized medicine that help patients is our engagement.
They consolidate their services with the collaboration of pharmaceutical companies and strategic partners. iC42 is your bioanalytical resource for the future!
- Toxicology (136 drugs of abuse + metabolites panel with simultaneous structural confirmation)
- Immunosuppressants (Tacrolimus, Cyclosporine, Sirolimus, Everolimus, Mycophenolic Acid)
- Assay Development
- Validation and Sample Analysis For Preclinical (including GLP)
- Epidemiology
- Clinical and Regulatory Clinical Studies
iC42 is CAP and CLIA certified.
iC42 is headquartered in Colorado, USA, but provides lab services globally.